本文選題：緩慢型心律失常　切入點(diǎn)：參鹿復(fù)律湯　出處：《遼寧中醫(yī)雜志》2017年06期

【摘要】：目的:探討參鹿復(fù)律湯聯(lián)合西藥治療緩慢型心律失常的療效及其可能作用機(jī)制。方法:隨機(jī)數(shù)字法將87例緩慢型心律失常患者分為觀察組(44例)與對(duì)照組(43例),觀察組采取參鹿復(fù)律湯聯(lián)合沙丁胺醇治療,對(duì)照組則給予單純沙丁胺醇治療,均干預(yù)2周,比較兩組臨床療效及安全性,并對(duì)治療前后中醫(yī)證候積分、24 h動(dòng)態(tài)心電圖及血液流變學(xué)指標(biāo)測(cè)定。結(jié)果:觀察組治療總有效率90.91%,顯著高于對(duì)照組的72.09%(P0.05);與治療前比較,兩組治療后心悸、胸悶、氣短、畏寒積分、高切全血黏度、低切全血黏度、血漿黏度均顯著下降,最快心率、最慢心率、平均心率均顯著上升,差異有統(tǒng)計(jì)學(xué)意義(P0.05),且觀察組治療后上述指標(biāo)均顯著優(yōu)于對(duì)照組(P0.05);觀察組治療后SDNN較治療前顯著提高,SDANN、RMSSD顯著降低,差異有統(tǒng)計(jì)學(xué)意義(P0.05),而對(duì)照組治療前后上述指標(biāo)比較無顯著差異(P0.05),觀察組治療后SDNN、SDANN、RMSSD與對(duì)照組比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:參鹿復(fù)律湯聯(lián)合西藥治療緩慢型心律失常安全有效,能明顯改善其臨床癥狀、心臟自主神經(jīng)功能及血流動(dòng)力學(xué)指標(biāo),提高心率。
[Abstract]:Objective: to investigate the therapeutic effect and possible mechanism of Shenlu Fulu decoction combined with western medicine in the treatment of bradyarrhythmia.Methods: 87 patients with bradyarrhythmia were randomly divided into two groups: the observation group (n = 44) and the control group (n = 43). The observation group was treated with Shenlu Fulu decoction combined with salbutamol, while the control group was treated with salbutamol alone for 2 weeks.The clinical efficacy and safety of the two groups were compared, and 24 h dynamic electrocardiogram and hemorheology were measured before and after treatment.Results: the total effective rate of treatment in the observation group was 90.91, which was significantly higher than that in the control group (72.09) (P 0.05), compared with that before treatment, palpitation, chest tightness, shortness of breath, chilling score, high shear viscosity, low shear viscosity, plasma viscosity and the fastest heart rate were observed in the two groups.The slowest heart rate and mean heart rate were significantly increased (P 0.05), and the above indexes in the observation group were significantly better than those in the control group (P 0.05), and the SDNN in the observation group was significantly higher than that in the control group (P 0.05), and the SDNN of the observation group was significantly lower than that of the control group (P < 0.05).The difference was statistically significant (P 0.05), but there was no significant difference before and after treatment in the control group (P 0.05). There was a significant difference between the observation group (P 0.05) and the control group (P 0.05).Conclusion: Shenlu Fulu decoction combined with western medicine is safe and effective in the treatment of bradyarrhythmia. It can obviously improve the clinical symptoms, cardiac autonomic nerve function and hemodynamics, and increase heart rate.
【作者單位】： 南陽市南陽醫(yī)專第一附屬醫(yī)院;
【分類號(hào)】：R541.7

【參考文獻(xiàn)】

相關(guān)期刊論文 前9條

1 梁蘊(yùn)瑜;鐘言;鄒旭;;鄒旭教授從“五臟相關(guān)”論治緩慢型心律失常經(jīng)驗(yàn)介紹[J];新中醫(yī);2016年07期

2 周單生;;穩(wěn)心顆粒治療伴室性心律失常心肌梗死的臨床觀察[J];解放軍醫(yī)藥雜志;2016年04期

3 李英;惠朋利;;中西醫(yī)結(jié)合治療心律失�；颊吲R床療效觀察及其安全性評(píng)價(jià)[J];湖北中醫(yī)藥大學(xué)學(xué)報(bào);2015年05期

4 周加興;;參仙生脈口服液治療緩慢性心律失常34例臨床觀察[J];四川中醫(yī);2015年10期

5 吉利;張s，

本文編號(hào)：1718224